The role of TRAIL in apoptosis and immunosurveillance in cancer

JM Pimentel, JY Zhou, GS Wu - Cancers, 2023 - mdpi.com
Simple Summary Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)
plays an important role in apoptosis and tumor immunosurveillance. Because TRAIL …

Survey of the year 2004 commercial optical biosensor literature

RL Rich, DG Myszka - Journal of Molecular Recognition: An …, 2005 - Wiley Online Library
The year 2004 represents a milestone for the biosensor research community: in this year,
over 1000 articles were published describing experiments performed using commercially …

The stability effects of protein mutations appear to be universally distributed

N Tokuriki, F Stricher, J Schymkowitz, L Serrano… - Journal of molecular …, 2007 - Elsevier
How the thermodynamic stability effects of protein mutations (ΔΔG) are distributed is a
fundamental property related to the architecture, tolerance to mutations (mutational …

Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor

AM van der Sloot, V Tur, E Szegezdi… - Proceedings of the …, 2006 - National Acad Sciences
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potential anticancer
drug that selectively induces apoptosis in a variety of cancer cells by interacting with death …

[HTML][HTML] A novel histone acetyltransferase inhibitor A485 improves sensitivity of non-small-cell lung carcinoma cells to TRAIL

B Zhang, D Chen, B Liu, FJ Dekker, WJ Quax - Biochemical pharmacology, 2020 - Elsevier
Transcriptional coactivators p300 and CBP catalyze the acetylation of lysine residues in
histone proteins. Upregulation of p300 and CBP has been associated with lung, colorectal …

In situ facile-forming PEG cross-linked albumin hydrogels loaded with an apoptotic TRAIL protein

I Kim, JS Choi, S Lee, HJ Byeon, ES Lee… - Journal of controlled …, 2015 - Elsevier
The key to making a practicable hydrogel for pharmaceutical or medical purposes is to
endow it with relevant properties, ie, facile fabrication, gelation time-controllability, and in …

Tumor necrosis factor–related apoptosis-inducing ligand pathway and its therapeutic implications

EGE De Vries, JA Gietema, S de Jong - Clinical cancer research, 2006 - AACR
Background Apoptosis can be executed through a mitochondria-dependent (intrinsic) and a
death receptor–dependent, mitochondria-independent (extrinsic) pathway. The intrinsic …

DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design

V Tur, AM van der Sloot, CR Reis, E Szegezdi… - Journal of Biological …, 2008 - ASBMB
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potential anticancer
agent that selectively induces apoptosis in a variety of cancer cells by interacting with death …

CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation

B Liu, OA Diaz Arguello, D Chen, S Chen, A Saber… - Plos one, 2020 - journals.plos.org
Receptor tyrosine kinases, such as VEGFR, PDGFR and EGFR, play important roles in renal
cancer. In this study, we investigated EGFR knockout as a therapeutic approach in renal cell …

Improving the chitinolytic activity of Bacillus pumilus SG2 by random mutagenesis

M Vahed, E Motalebi, G Rigi, KA Noghabi… - … of microbiology and …, 2013 - koreascience.kr
Bacillus pumilus SG2, a halotolerant strain, expresses two major chitinases designated ChiS
and ChiL that were induced by chitin and secreted into the supernatant. The present work …